Screening, Assessment, and Care of Anxiety and Depressive Symptoms in Adults With Cancer: An American Society of Clinical Oncology Guideline Adaptation
Screening, Assessment, and Care of Anxiety and Depressive Symptoms in Adults With Cancer: An American Society of Clinical Oncology Guideline Adaptation
复制标题
DOI：
10.1200/jco.2013.52.4611
复制
发表时间：
2014-05-20
影响因子：
45.3
通讯作者：
Rowland, Julia H.
中科院分区：
文献类型：
--
作者：
Andersen, Barbara L.;DeRubeis, Robert J.;Rowland, Julia H.
目的确定一份关于成人癌症患者心理社会困扰(抑郁、焦虑)筛查、评估和护理的泛加拿大实践指南，以适应该指南。结果在泛加拿大指南内容审查的基础上，ASCO专家组一致认为，总的来说，这些建议是明确、彻底的，基于最相关的科学证据，并提出了患者可以接受的选择。然而，对于泛加拿大指南中涉及的一些主题，ASCO小组根据特设小组成员的当地背景和实践信念制定了一套经过调整的建议。建议在整个护理过程中定期评估所有癌症患者的抑郁和焦虑症状。评估应使用经过验证的、已公布的措施和程序进行。根据症状程度和补充信息，建议采用不同的治疗途径。未能识别和治疗焦虑和抑郁会增加生活质量不佳的风险，并可能增加与疾病相关的发病率和死亡率。这一指南调整是更大的生存指南系列的一部分。结论尽管临床医生可能无法预防癌症的一些慢性或晚期医学影响，但他们在减轻负面情绪和行为后遗症方面发挥了至关重要的作用。有效地识别和治疗那些表现出焦虑或抑郁症状的人，将降低人类患癌症的成本。(C)美国临床肿瘤学会2014年
PurposeA Pan-Canadian Practice Guideline on Screening, Assessment, and Care of Psychosocial Distress (Depression, Anxiety) in Adults With Cancer was identified for adaptation.MethodsAmerican Society of Clinical Oncology (ASCO) has a policy and set of procedures for adapting clinical practice guidelines developed by other organizations. The guideline was reviewed for developmental rigor and content applicability.ResultsOn the basis of content review of the pan-Canadian guideline, the ASCO panel agreed that, in general, the recommendations were clear, thorough, based on the most relevant scientific evidence, and presented options that will be acceptable to patients. However, for some topics addressed in the pan-Canadian guideline, the ASCO panel formulated a set of adapted recommendations based on local context and practice beliefs of the ad hoc panel members. It is recommended that all patients with cancer be evaluated for symptoms of depression and anxiety at periodic times across the trajectory of care. Assessment should be performed using validated, published measures and procedures. Depending on levels of symptoms and supplementary information, differing treatment pathways are recommended. Failure to identify and treat anxiety and depression increases the risk for poor quality of life and potential disease-related morbidity and mortality. This guideline adaptation is part of a larger survivorship guideline series.ConclusionAlthough clinicians may not be able to prevent some of the chronic or late medical effects of cancer, they have a vital role in mitigating the negative emotional and behavioral sequelae. Recognizing and treating effectively those who manifest symptoms of anxiety or depression will reduce the human cost of cancer. (C) 2014 by American Society of Clinical Oncology